AzTrials
AzTrials

DementiaNCT03865758

Improving the Rehabilitation Process

A study testing IN2L computer system in people with Dementia, run by Penn State University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A major challenge in care of persons with dementia is that illness and hospitalizations can lead to significant decreases in functional abilities. Maintaining functional abilities as high as possible is a key goal in dementia care, because persons are able to function optimally despite cognitive problems and engage in… Read more about this study

Who is it for?
Any age
Conditions the study is for
Dementia
What is being tested?
IN2L computer system
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
2 sitesUnited States
Study dates
31 Mar 2018to 30 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Probable dementia indicated by prior diagnosis and/or a score of 23 or less on the Brief Alzheimer Screen.

Who cannot join

  • No evidence of dementia

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Presbytyerian SeniorCare

    Oakmont, Pennsylvania, 15139

  • Presbyterian SeniorCare Southmont

    Washington, Pennsylvania, 15301

Other trials in United States

About this study

A major challenge in care of persons with dementia is that illness and hospitalizations can lead to significant decreases in functional abilities. Maintaining functional abilities as high as possible is a key goal in dementia care, because persons are able to function optimally despite cognitive problems and engage in more preferred and enjoyable activities. Functional decline can be ameliorated through rehabilitation, building strength, balance and functional competencies. People with dementia, however, may not able to engage fully in rehabilitation due to their cognitive problems. They may not understand the therapist's instructions and may be fearful of what the therapist is trying to do.

The proposed study will test the efficacy of a multifunctional interactive computer system, the IN2L, that uses video and audio to engage people more fully in rehabilitation. Music and videos elicit and sustain responses that contribute to rehabilitation goals such as increasing balance or strength. With the IN2L, audio and video material that matches the preferences and past experience of the person in rehabilitation can be selected. While this approach shows promise with rehabilitation patients generally, it has particular potential for application with persons with dementia. Specifically, when Physical or Occupational Therapists (PT and OT) are not able to engage a person with dementia in rehabilitation tasks using verbal instructions and explanations, they may be able to involve the person using audio and video stimuli that draw upon abilities that have remained intact despite the disease.

Read more

To determine the efficacy of IN2L, the study will use a quasi-experimental design that compares rehabilitation patients with dementia seen at two comparable facilities operated by Presbyterian Senior Care Network. In one facility, the Willows, OT and PT currently use IN2L. In the comparison facility, (Southmont), OT and PT do not currently have access to IN2L. This type of design is optimal, because it prevents contamination effects that could occur with random assignment within the same facility. In that case, therapists in the control condition who were working side-by-side with therapists using IN2L would be likely to incorporate IN2L techniques in their therapy sessions if they perceived it to be useful.

The study will use observational and self-report by patients and their therapists measures to determine if persons with dementia in rehabilitation show greater participation in rehabilitation activities, better attainment of rehabilitation goals and functional improvement when therapists use the IN2L compared to usual therapy approaches.

Read the detailed description

The objective of the study is to evaluate the effectiveness of the use of a multifunctional interactive computer system, the IN2L. that uses video and audio to engage people with dementia more fully in rehabilitation. The study will compare people seen at a facility where physical therapists (PT) and occupational therapists (OT) currently use IN2L as part of the rehabilitation program (the Willows) with a comparable facility (Southmont) in a different locale that does not currently use the IN2L system. Both rehabilitation facilities are operated by the same organization, Presbyterian SeniorCare Network, which provides comprehensive residential, inpatient and outpatient services to older adults in Western Pennsylvania. The two rehabilitation units function in similar ways apart from use of IN2L. The study evaluates procedures already in place, rather than introducing a new experimental protocol. Participants in the research will receive exactly the same treatment at each facility as they would if they did not participate in the research. To evaluate effectiveness, observational measures of participants' engagement in treatment sessions and information provided by therapists about goal attainment over the course of the therapy will be used.

The study will test the following hypotheses:

  1. Patients whose therapists use IN2L will show greater increases in engagement during occupational and physical therapy sessions than patients receiving treatment as usual (without IN2L).
  2. Patients whose therapists used IN2L in treatment will show greater attainment of therapy goals than patients receiving treatment as usual.
  3. Levels and improvement in engagement will account for (mediate) the association of treatment (IN2L use) with greater goal attainment.

The study will also test the following research question:

  1. Patients whose therapists used IN2L in treatment will maintain functioning better at 3 months and have lower rates of falls and hospitalizations.

Maintaining functional abilities is a key goal in dementia care, because persons with dementia (PWD) are then able to engage in more preferred and enjoyable activities despite their cognitive problems. Functional decline is often due to inactivity, such as when a person with dementia is restricted to bed during a hospitalization, or otherwise cannot engage in usual activities. This type of functional decline as well as problems caused directly by illness can often be ameliorated through a rehabilitation program that builds strength and balance and other functional competencies. People with dementia, however, are often not able to engage fully in rehabilitation due to their cognitive problems. They may not understand the therapist's instructions and may be fearful of what the therapist is trying to do. Finding more optimal ways of engaging people with dementia in rehabilitation may help them maintain better functioning, which will allow them to engage in more usual and preferred activities. Better functioning may also lead to lower costs of care by helping people with dementia stay at home longer, or by their requiring less assistance in residential care facilities.

The IN2L was developed specifically to engage people with dementia by presenting familiar and lively visual and auditory stimuli. Given the variability in functioning among persons with dementia, the mode and content of the stimuli need to be varied. The IN2L system allows therapists to draw upon extensive visual and auditory materials so that they can present something likely to be familiar and enjoyable to the person, and if that does not work, to try something else. By giving therapists more tools other than just persuasion, they can gain the attention of persons with dementia and use the video and music to engage them in activities that address rehabilitation goals. The IN2L has been in use at several rehabilitation facilities in the country and has been found to be feasible and acceptable to patients and therapists. It has not, however, been evaluated for its impact on rehabilitation outcomes.

The present study will use a quasi-experimental two group design to compare persons with dementia who receive rehabilitation services at a facility (The Willows) that uses the IN2L to assist in treatment and a facility (Southmont) that does not use the IN2L. Both rehabilitation units are operated by the same organization, Presbyterian SeniorCare. The units have similar levels of staffing and use similar procedures. A quasi-experimental design is appropriate for this type of study. If randomization was used within a rehabilitation unit, patients and therapists in the control condition would see other patients and therapists using the IN2L, and could request use of the IN2L or perceive they are receiving a lesser form of treatment. A quasi-experimental design prevents this type of contamination. Furthermore, quasi-experimental designs with equivalent groups have been shown to be as effective as randomized trial in controlling threats to internal validity and yield reliable findings.

A potential limitation of the design is that therapists in the control unit (Southmont) were aware of the use of the IN2L at The Willows, and so could not be blinded to the intervention. During the orientation to the study for therapists at Southmont, the PI emphasized that their use of their professional skills could result in similar outcomes to The Willows. There was no indication in their comments that they believed that the IN2L was a better approach than usual treatment.

The project is recruiting 50 persons with dementia at each facility (total N = 100). All persons will be consented and where an initial validated screening indicates limited comprehension to give consent, the individual's legally appointed representative (LAR) will be contacted to give consent.

Once enrolled, participants will receive the usual treatments at each setting. Research assistants (RA) at each setting will conduct an initial interview, and conduct observations of OT and PT therapy sessions. The RAs and therapists will each complete ratings of engagement in each session, using the Pittsburgh Rehabilitation Participation Scale (PRPS). Initial reliability between the RAs and PI and the RAs and therapists were established. At completion of treatment, the RAs will conduct another interview obtaining qualitative responses to treatment, including responses to the IN2L for participants at The Willows. Following standard procedures, therapists will assess functioning across a standard set of domains at baseline, and identify individualized goals. At the completion of treatment, they will again assess functioning and indicate on a standardized scale if goals had been met.

The RAs will also conduct brief follow up interviews at one and three months after completion of treatment.

Data analysis:

To test hypothesis 1 (Patients whose therapists use IN2L will show greater increases in engagement during occupational and physical therapy sessions than patients receiving treatment as usual), multilevel models with observations nested within persons will be used. These models test for differences in slope (change) and daily variability between the treatment and control groups. Covariates such as cognitive functioning, age, gender, that show associations with the dependent measures will be included in the model.

For hypothesis 2 (Patients whose therapists used IN2L in treatment will show greater attainment of therapy goals than patients receiving treatment as usual), a MANOVA will be used with relevant covariates to test for differences in mean goal attainment between groups.

For hypothesis 3, If findings indicate that treatment affects engagement or goal attainment, a multilevel model will be used to conduct a mediational analysis to test if increases in engagement are associated with better goal attainment.

The additional research question (Patients whose therapists used IN2L in treatment will maintain functioning better at 3 months and have lower rates of falls and hospitalizations) will be tested using data obtained at the one and three month follow up interviews.

Conditions
Dementia
Being tested
IN2L computer system
Keywords
Dementia, Rehabilitation
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IN2L computer systemDevice

    Therapists will use the IN2L computer system to choose videos, music, games and exercise specific to the rehabilitation needs and personal preferences of patients.

Study groups in NCT03865758
Study groupRoleWhat they receive
IN2L enhanced therapyExperimentalThe intervention to be delivered is the use of the IN2L computer system to deliver video, music, and exercises to patients receiving physical and occupational therapy. Therapists will select the specific IN2L that will be most appropriate given each person's rehabilitation goals and personal preferences.
Receives: Device: IN2L computer system
Usual OT and PT services without IN2LNo interventionThe intervention to be delivered is physical therapy and occupational therapy to improve functioning.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pittsburgh Rehabilitation Participation Scale (PRPS)

    Measures change in engagement in therapy from the beginning to the end of rehabilitation. Scores range from 0--no engagement to 5--excellent engagement. Higher scores indicate a better outcome. There are no subscales.

    Measured: The PRPS is scored on multiple occasions for each subject following completion of OT and PT sessions from the time of enrollment in the study until treatment completion (on average 10 days).

  2. Functional Independence Scale

    Measures change in functioning independence of patients from beginning to end of treatment. The scale consists of 42 items that are each rated using a reliable 10 point rating system. Scores on each function range from completely dependent (score of 0) to independent (score of 10). There are 2 subscales: items rated by physical therapists (13, range 0 to 130) and items rated by occupational therapists (29, range 0 to 290). Higher scores indicated better functioning.

    Measured: The Functional Independence Scale is administered two times: prior to treatment and again at the completion of treatment (on average 10 days later)

  3. Goal Attainment: Percent of Rehabilitation Goals Attained.

    The measure assesses the percent of rehabilitation goals attained by patients. Goals are set by OT and PT at initial assessment. Attainment is determined based on comparison of Functional Independent scores at baseline and completion of treatment. Scores for goal attainment are: (1) did not attain goal; (2) attained goal; and (3) exceeded goal. The number of goals set initially varies across patients. For that reason, goal attainment scores will be summed for each person and the sum then divided by the number of goals that were initially set. This creates a comparable score across persons, which has a range from 1 to 3. Analyses will be conducted using this mean-item score for goals. Secondary analyses will look at the mean-item score for goals set by PTs and by OTs separately.

    Measured: Scored at the completion of treatment, usually 10 days to two weeks after subjects enter the study.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2019
  2. Study start31 Mar 2018
  3. Primary completion31 May 2019
  4. Study completion30 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The study will use a quasi-experimental design, comparing patients from two similar rehabilitation units operated by the same organization who have similar patient populations.
Masking
None (open label)
Enrolment
98 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03865758
Sponsor's protocol ID
00007754
Status last verified
Aug 2020
First submitted
28 Feb 2019
Last updated
28 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lenze EJ, Munin MC, Quear T, Dew MA, Rogers JC, Begley AE, Reynolds CF 3rd. The Pittsburgh Rehabilitation Participation Scale: reliability and validity of a clinician-rated measure of participation in acute rehabilitation. Arch Phys Med Rehabil. 2004 Mar;85(3):380-4. doi: 10.1016/j.apmr.2003.06.001.

    PubMed 15031821
  • Morghen S, Morandi A, Guccione AA, Bozzini M, Guerini F, Gatti R, Del Santo F, Gentile S, Trabucchi M, Bellelli G. The association between patient participation and functional gain following inpatient rehabilitation. Aging Clin Exp Res. 2017 Aug;29(4):729-736. doi: 10.1007/s40520-016-0625-3. Epub 2016 Sep 2.

    PubMed 27590904
  • Zarit SH, Chiusano C, Harrison AS, Sewell L, Krause C, Liu Y. Rehabilitation of persons with dementia: using technology to improve participation. Aging Ment Health. 2021 Mar;25(3):543-550. doi: 10.1080/13607863.2020.1711864. Epub 2020 Jan 16.

    PubMed 31941356

Questions about this trial

What is this clinical trial studying?

A study testing IN2L computer system in people with Dementia, run by Penn State University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pittsburgh Rehabilitation Participation Scale (PRPS) (time frame: The PRPS is scored on multiple occasions for each subject following completion of OT and PT sessions from the time of enrollment in the study until treatment completion (on average 10 days).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03865758, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in